These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15577006)

  • 1. [Medication counseling in the oral medicine of osteoporosis and complications with elderly people].
    Obara A
    Clin Calcium; 2004 Mar; 14(3):447-51. PubMed ID: 15577006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to patient education: emphasizing the long-term value of compliance and persistence.
    Gold DT; McClung B
    Am J Med; 2006 Apr; 119(4 Suppl 1):S32-7. PubMed ID: 16563940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Instruction on the use of drugs to an osteoporosis curative medicine].
    Miura T; Suzuki H
    Nihon Rinsho; 2003 Feb; 61(2):274-9. PubMed ID: 12638221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient counseling for osteoporosis prevention.
    Bartlett EE
    Public Health Rep; 1989; 104 Suppl(Suppl):84-7. PubMed ID: 2517708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with osteoporosis medications.
    Solomon DH; Avorn J; Katz JN; Finkelstein JS; Arnold M; Polinski JM; Brookhart MA
    Arch Intern Med; 2005 Nov; 165(20):2414-9. PubMed ID: 16287772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.
    Gold DT; Alexander IM; Ettinger MP
    Ann Pharmacother; 2006 Jun; 40(6):1143-50. PubMed ID: 16735667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A medication use evaluation of alendronate: compliance with administration guidelines.
    Mersfelder T; Armitstead JA; Ivey MF; Cedars M
    Pharm Pract Manag Q; 1999 Jan; 18(4):50-8. PubMed ID: 10339068
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long term oral anticoagulation: indications and problems].
    Robert-Ebadi H; Boehlen F
    Rev Med Suisse; 2008 Feb; 4(143):343-6, 348-9. PubMed ID: 18386670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Task analysis of patients' medication-taking practice and the role of making sense: a grounded theory study.
    Bajcar J
    Res Social Adm Pharm; 2006 Mar; 2(1):59-82. PubMed ID: 17138501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Counseling of osteoporosis patients. To take time for the patient].
    Semler J
    MMW Fortschr Med; 2005 Aug; 147(31-32):45. PubMed ID: 16128199
    [No Abstract]   [Full Text] [Related]  

  • 13. Medication counseling center in a teaching hospital.
    Mishra P; Subish P; Upadhyay DK; Bista S; Alam K; Bhandari RB
    JNMA J Nepal Med Assoc; 2005; 44(160):129-34. PubMed ID: 16751815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population.
    Huybrechts KF; Ishak KJ; Caro JJ
    Bone; 2006 Jun; 38(6):922-8. PubMed ID: 16330270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
    Emkey RD; Ettinger M
    Am J Med; 2006 Apr; 119(4 Suppl 1):S18-24. PubMed ID: 16563937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors contributing to compliance with osteoporosis medication.
    Kertes J; Dushenat M; Vesterman JL; Lemberger J; Bregman J; Friedman N
    Isr Med Assoc J; 2008 Mar; 10(3):207-13. PubMed ID: 18494234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blalock SJ; Norton LL; Patel RA; Dooley MA
    Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient education and consumer medicine information: a study of provision by Queensland rural and remote area Registered Nurses.
    Hegney D; Plank A; Watson J; Raith L; McKeon C
    J Clin Nurs; 2005 Aug; 14(7):855-62. PubMed ID: 16000099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient counseling by pharmacist - a focus on chronic illness.
    Palaian S; Prabhu M; Shankar PR
    Pak J Pharm Sci; 2006 Jan; 19(1):65-72. PubMed ID: 16632457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.